Over 20% of the world's population suffers from ocular allergies, with allergic conjunctivitis being the most common and irritating form. Allergic conjunctivitis causes inflammation of the conjunctiva due to allergic reactions. A new drug called Olarif DS is positioned as the best treatment for allergic conjunctivitis, as it provides faster symptom relief and is safer and better tolerated than alternatives. The document recommends marketing Olarif DS to ophthalmologists, pediatricians, and other doctors for uses including seasonal allergic conjunctivitis, perennial allergic conjunctivitis, allergic keratitis, and allergic keratoconjunctivitis.
3. More than 20% population of the world is
usually affected by different types of Ocular
Allergies.
Allergic conjunctivitis is the
most common and the most
irritating one.
4. Conjunctivitis
Inflammation of the conjunctiva is
called conjunctivitis
1. Bacterial Conjunctivitis
2. Viral Conjunctivitis
3. Allergic Conjunctivitis
5. Allergic conjunctivitis is inflammation
of the conjunctiva due to allergic
activities
Allergic Conjunctivitis
8. Ensures excellent efficacy and greater tolerability2
…greater patient satisfaction by rapid symptomatic relief
9. •The best option for Allergic
Conjunctivitis treatment
•Better than Ephinastine in preventing
ocular itching & redness
•Ensures excellent efficacy and
greater tolerability
•Safe for children and adolescent
•Safe for long term use
12. Action Plan
• Select Five doctors of your territory who are
prescribing Olopatadine DS
• Convey the special advantages of Olarif DS over
the competitor’s brands.
• Visit these doctors frequently until prescription
is achieved.
• Monitor prescription share of loyal doctors
• Make the best use of physician’s sample and
promotional tools to the target doctors for
increasing prescription support
